Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
Completed
- Conditions
- Cancer
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Daynamica, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT06322992
- Locations
- 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States
News
No news found